{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:31:21Z","timestamp":1787509881257,"version":"build-2736575974"},"reference-count":56,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671165"],"award-info":[{"award-number":["81671165"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.heliyon.2024.e31875","type":"journal-article","created":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T12:29:50Z","timestamp":1716640190000},"page":"e31875","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pan-cancer analysis of the disulfidptosis-related gene RPN1 and its potential biological function and prognostic significance in gliomas"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-6304-178X","authenticated-orcid":false,"given":"Yan","family":"Zong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3885-3730","authenticated-orcid":false,"given":"Ankang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiji","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinuo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9942-4820","authenticated-orcid":false,"given":"Xingcai","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.heliyon.2024.e31875_bib1","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA A Cancer J. Clin."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e31875_bib2","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/CM9.0000000000001474","article-title":"Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020","volume":"134","author":"Cao","year":"2021","journal-title":"Chin. Med. J."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e31875_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrc.2015.4","article-title":"DNA repair, genome stability and cancer: a historical perspective","volume":"16","author":"Jeggo","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e31875_bib4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41568-023-00557-7","article-title":"Nucleotide metabolism: a pan-cancer metabolic dependency","volume":"23","author":"Mullen","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e31875_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-32180-0","article-title":"G2Vec: distributed gene representations for identification of cancer prognostic genes","volume":"8","author":"Choi","year":"2018","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e31875_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/genes9100478","article-title":"An improved method for prediction of cancer prognosis by network learning","volume":"9","author":"Kim","year":"2018","journal-title":"Genes"},{"issue":"15","key":"10.1016\/j.heliyon.2024.e31875_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158489","article-title":"Pan-cancer analysis identifies CHD5 as a potential biomarker for glioma","volume":"23","author":"Xu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e31875_bib8","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.18632\/aging.203862","article-title":"Pan-cancer analysis reveals NUP37 as a prognostic biomarker correlated with the immunosuppressive microenvironment in glioma","volume":"14","author":"He","year":"2022","journal-title":"Aging (Albany NY)"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e31875_bib9","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/neuonc\/nou087","article-title":"The epidemiology of glioma in adults: a \u201cstate of the science\u201d review","volume":"16","author":"Ostrom","year":"2014","journal-title":"Neuro Oncol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e31875_bib10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12943-022-01513-z","article-title":"Glioma targeted therapy: insight into future of molecular approaches","volume":"21","author":"Yang","year":"2022","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e31875_bib11","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.molcel.2020.05.014","article-title":"Cell death in the origin and treatment of cancer","volume":"78","author":"Strasser","year":"2020","journal-title":"Mol. Cell"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e31875_bib12","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e31875_bib13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: molecular mechanisms and health implications","volume":"31","author":"Tang","year":"2021","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e31875_bib14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13046-023-02712-2","article-title":"Disulfidptosis: a new form of programmed cell death","volume":"42","author":"Zheng","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e31875_bib15","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41556-023-01091-2","article-title":"Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis","volume":"25","author":"Liu","year":"2023","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.heliyon.2024.e31875_bib16","article-title":"Crosstalk of disulfidptosis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in bladder cancer based on a machine learning survival framework","volume":"14","author":"Zhao","year":"2023","journal-title":"Front. Endocrinol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e31875_bib17","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4196\/kjpp.2023.27.4.333","article-title":"Circ-SNX27 sponging miR-375\/RPN1 axis contributes to hepatocellular carcinoma progression","volume":"27","author":"Zheng","year":"2023","journal-title":"KOREAN J. PHYSIOL. PHARMACOL."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e31875_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1615\/CritRevEukaryotGeneExpr.2023048536","article-title":"Prognosis prediction of disulfidptosis-related genes in bladder cancer and a comprehensive analysis of immunotherapy","volume":"33","author":"Jiang","year":"2023","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"issue":"W1","key":"10.1016\/j.heliyon.2024.e31875_bib19","doi-asserted-by":"crossref","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e31875_bib20","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nmeth.1607","article-title":"A roadmap to generate renewable protein binders to the human proteome","volume":"8","author":"Colwill","year":"2011","journal-title":"Nat. Methods"},{"key":"10.1016\/j.heliyon.2024.e31875_bib21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cmpb.2018.10.020","article-title":"compound.Cox: univariate feature selection and compound covariate for predicting survival","volume":"168","author":"Emura","year":"2019","journal-title":"Comput. Methods Progr. Biomed."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e31875_bib22","doi-asserted-by":"crossref","DOI":"10.2196\/27633","article-title":"Web-based survival analysis tool tailored for medical research (KMplot): development and implementation","volume":"23","author":"Lanczky","year":"2021","journal-title":"J. Med. Internet Res."},{"issue":"21","key":"10.1016\/j.heliyon.2024.e31875_bib23","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","article-title":"TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Res."},{"issue":"W1","key":"10.1016\/j.heliyon.2024.e31875_bib24","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.heliyon.2024.e31875_bib25","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","article-title":"UALCAN: an update to the integrated cancer data analysis platform","volume":"25","author":"Chandrashekar","year":"2022","journal-title":"Neoplasia"},{"issue":"269","key":"10.1016\/j.heliyon.2024.e31875_bib26","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.heliyon.2024.e31875_bib27","article-title":"Landscape of microsatellite instability across 39 cancer types","volume":"2017","author":"Bonneville","year":"2017","journal-title":"JCO Precis Oncol."},{"key":"10.1016\/j.heliyon.2024.e31875_bib28","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/1471-2164-10-277","article-title":"CellMiner: a relational database and query tool for the NCI-60 cancer cell lines","volume":"10","author":"Shankavaram","year":"2009","journal-title":"BMC Genom."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e31875_bib29","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","article-title":"Nomograms in oncology: more than meets the eye","volume":"16","author":"Balachandran","year":"2015","journal-title":"Lancet Oncol."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e31875_bib30","first-page":"e1866","article-title":"Autologous natural killer cells as a promising immunotherapy for locally advanced colon adenocarcinoma: three years follow-up of resectable case","volume":"6","author":"Bagus","year":"2023","journal-title":"Cancer Rep. (Hoboken)"},{"key":"10.1016\/j.heliyon.2024.e31875_bib31","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1017\/erm.2021.4","article-title":"Methylation multiplicity and its clinical values in cancer","volume":"23","author":"Dai","year":"2021","journal-title":"Expet Rev. Mol. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e31875_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100336","article-title":"Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers","volume":"7","author":"Palmeri","year":"2022","journal-title":"ESMO Open"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e31875_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13030558","article-title":"PD-L1, TMB, MSI, and other predictors of response to immune checkpoint inhibitors in biliary tract cancer","volume":"13","author":"Rizzo","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.heliyon.2024.e31875_bib34","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejca.2022.03.033","article-title":"High tumor mutational burden (TMB) identifies a microsatellite stable pancreatic cancer subset with prolonged survival and strong anti-tumor immunity","volume":"169","author":"Karamitopoulou","year":"2022","journal-title":"Eur. J. Cancer"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e31875_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0191-1","article-title":"Immune checkpoint inhibitors: recent progress and potential biomarkers","volume":"50","author":"Darvin","year":"2018","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e31875_bib36","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13046-023-02675-4","article-title":"Disulfidptosis: a new target for metabolic cancer therapy","volume":"42","author":"Zheng","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.heliyon.2024.e31875_bib37","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7270541","article-title":"RPNs levels are prognostic and diagnostic markers for hepatocellular carcinoma","volume":"2022","author":"Zheng","year":"2022","journal-title":"J Oncol"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e31875_bib38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/35056563","article-title":"Themes and variations on ubiquitylation","volume":"2","author":"Weissman","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e31875_bib39","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.2703","article-title":"Innate and adaptive immune cells in the tumor microenvironment","volume":"14","author":"Gajewski","year":"2013","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e31875_bib40","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","article-title":"Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives","volume":"20","author":"Mao","year":"2021","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e31875_bib41","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ccell.2017.06.010","article-title":"Conditional selection of genomic alterations dictates cancer evolution and oncogenic dependencies","volume":"32","author":"Mina","year":"2017","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e31875_bib42","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41571-018-0002-6","article-title":"The emerging clinical relevance of genomics in cancer medicine","volume":"15","author":"Berger","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"7793","key":"10.1016\/j.heliyon.2024.e31875_bib43","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41586-020-1970-0","article-title":"Genomic basis for RNA alterations in cancer","volume":"578","author":"Group","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2024.e31875_bib44","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-012414-040424","article-title":"DNA replication stress as a hallmark of cancer","volume":"10","author":"Macheret","year":"2015","journal-title":"Annu. Rev. Pathol."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e31875_bib45","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1080\/15476286.2017.1318241","article-title":"The chemistries and consequences of DNA and RNA methylation and demethylation","volume":"14","author":"Traube","year":"2017","journal-title":"RNA Biol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e31875_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/nu11030608","article-title":"Methyl donor micronutrients that modify DNA methylation and cancer outcome","volume":"11","author":"Mahmoud","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.heliyon.2024.e31875_bib47","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.3389\/fimmu.2020.02039","article-title":"Crosstalk between the MSI status and tumor microenvironment in colorectal cancer","volume":"11","author":"Lin","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e31875_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102175","article-title":"Microsatellite instability in Gastric Cancer: between lights and shadows","volume":"95","author":"Puliga","year":"2021","journal-title":"Cancer Treat Rev."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e31875_bib49","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41588-018-0312-8","article-title":"Tumor mutational load predicts survival after immunotherapy across multiple cancer types","volume":"51","author":"Samstein","year":"2019","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e31875_bib50","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41589-021-00947-8","article-title":"GCN2 kinase activation by ATP-competitive kinase inhibitors","volume":"18","author":"Tang","year":"2022","journal-title":"Nat. Chem. Biol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e31875_bib51","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.heliyon.2024.e31875_bib52","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1016\/j.csbj.2022.06.046","article-title":"Identifies microtubule-binding protein CSPP1 as a novel cancer biomarker associated with ferroptosis and tumor microenvironment","volume":"20","author":"Wang","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.heliyon.2024.e31875_bib53","article-title":"Identification of cuproptosis-related subtypes and the development of a prognostic model in glioma","volume":"14","author":"Wu","year":"2023","journal-title":"Front. Genet."},{"issue":"6288","key":"10.1016\/j.heliyon.2024.e31875_bib54","doi-asserted-by":"crossref","first-page":"aad3018","DOI":"10.1126\/science.aad3018","article-title":"The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas","volume":"352","author":"Quail","year":"2016","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e31875_bib55","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2174\/156800909788166637","article-title":"Hypoxia helps glioma to fight therapy","volume":"9","author":"Amberger-Murphy","year":"2009","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.heliyon.2024.e31875_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1098482","article-title":"Roles of STAT3 in the pathogenesis and treatment of glioblastoma","volume":"11","author":"Fu","year":"2023","journal-title":"Front. Cell Dev. Biol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024079064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024079064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T23:39:00Z","timestamp":1761781140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024079064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":56,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2405844024079064"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e31875","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pan-cancer analysis of the disulfidptosis-related gene RPN1 and its potential biological function and prognostic significance in gliomas","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e31875","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e31875"}}